Paper
Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents.
Published Feb 15, 2005 · D. Gupta, N. Ghosh, R. Chandra
Bioorganic & medicinal chemistry letters
Q2 SJR score
71
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Non-RCT
Animal Study
Highly CitedStudy Snapshot
Compound 4a, a substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivative
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Advances in the Chemistry of Thiazolidinediones as Antidiabetic Agents
Thiazolidinediones effectively reduce insulin resistance and potentiate insulin action in type 2 non insulin-dependent diabetes patients, with potential for future diabetes treatments.
2005·3citations·N. Ghosh et al.·ChemInform
ChemInform
Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
The maleate salt of unsaturated TZD 5a is a potent euglycemic and hypolipidemic compound, with potential for use in diabetes treatment and obesity management.
1999·48citations·B. Lohray et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat
BRL 49653 reduces lipid availability and improves insulin action and glucose regulation in rats, with its effects mainly mediated by altered lipid availability.
1994·250citations·N. Oakes et al.·Diabetes
Diabetes
The ivsulin resistance syndrome
The insulin resistance syndrome is a complex, genetically influenced cluster of metabolic, anthropometric, and hemodynamic changes that may predispose individuals to non-insulin-dependent diabetes, hypertension, dyslipidemia, and atherogenic potential.
1992·10citations·E. Ferrannini·Current Opinion in Nephrology and Hypertension
Current Opinion in Nephrology and Hypertension
Hypoglycaemic and anti-hyperglycaemic drugs for the control of diabetes
This review explores the effectiveness of oral glucose-lowering agents for non-insulin-dependent diabetes mellitus and questions the need for distinguishing between hypoglycaemic and antihyperglycaemic agents.
1991·7citations·C. Bailey·Proceedings of the Nutrition Society
Proceedings of the Nutrition Society
Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds.
Pioglitazone and its analogues show similar hypoglycemic and hypolipidemic activity in genetically obese and diabetic mice, while thia-analogues and benzylideneheterocycles show decreased activity.
1991·262citations·Y. Momose et al.·Chemical & pharmaceutical bulletin
Chemical & pharmaceutical bulletin
Studies on hindered phenols and analogues. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation.
CS-045 shows potential as a hypoglycemic and hypolipidemic agent with its ability to inhibit lipid peroxidation without liver weight increase.
1989·195citations·T. Yoshioka et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and ob/ob Mice and Zucker Fatty Rats
CS-045 is a new oral antidiabetic agent that effectively reduces glucose and lipid metabolism in insulin-resistant diabetic animal models without reducing food intake or body weight.
1988·481citations·T. Fujiwara et al.·Diabetes
Diabetes
Citations
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
TZD derivatives show potential as effective and low-toxicity anticancer agents, with potential to overcome drug resistance and improve therapeutic efficacy and selectivity.
2024·1citation·M. Viji et al.·Journal of Molecular Structure
Journal of Molecular Structure
Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells
Bromo-substituted quinoxalines show promising anticancer activity, with compounds 4b and 4m showing comparable activity to 5-fluorouracil, making them a promising avenue for further research and development in anticancer therapeutics.
2024·0citations·Jia-Hua Liang et al.·RSC Advances
RSC Advances
Advances in Isocyanide‐Based Multicomponent Synthesis of Quinoxaline Scaffolds
Isocyanide-based multicomponent reactions enable the synthesis of diverse natural product mimetic scaffolds, potentially leading to complex bioactive natural products and synthetic pharmaceuticals.
2023·1citation·Monu Agarwal et al.·ChemistrySelect
ChemistrySelect
Synthesis of raloxifene-like quinoxaline derivatives by intramolecular electrophilic cyclization with disulfides.
Raloxifene-like quinoxaline derivatives show high cytotoxicity against breast cancer cells and human leukemia cells, but not against normal human lung fibroblasts.
2023·2citations·Yuhi Umezu et al.·Bioorganic & medicinal chemistry letters
Bioorganic & medicinal chemistry letters
Greener Pastures in Evaluating Antidiabetic Drug for a Quinoxaline Derivative: Synthesis, Characterization, Molecular Docking, in Vitro and HSA/DFT/XRD Studies
MOQTA, a new quinoxaline derivative, shows potential as a potent antidiabetic drug through its synthesis, characterization, and molecular docking studies.
2022·17citations·M. Missioui et al.·Arabian Journal of Chemistry
Arabian Journal of Chemistry
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities.
Multifunctional quinoxalinones possess various biological activities, including anticancer, neuroprotective, and neuroprotective properties, making them promising structures for medicinal chemistry.
2022·49citations·Xiaoying Jiang et al.·European journal of medicinal chemistry
European journal of medicinal chemistry
Synthesis and Antimicrobial Activity of (Z)-2-(4-((5-((1-Benzylpiperidin-4-yl)methylene)- 2,4-dioxothiazolidin-3-yl)methyl)-1H-1,2,3-triazol-1-yl)-N-phenylacetamides
The synthesized (CF-4a-o) derivatives show promising antimicrobial activity against various bacteria and fungi, with potential for broad biological applications.
2021·0citations·Ashok Rathod et al.·Asian Journal of Organic & Medicinal Chemistry
Asian Journal of Organic & Medicinal Chemistry